Nuclear cardiology is no longer a medical discipline residing solely in nuclear medicine. This is the first book to recognize this fact by integrating in-depth information from both the clinical cardiology and nuclear cardiology literature, and acknowledging cardiovascular medicine as the fundamental knowledge base needed for the practice of nuclear cardiology. The book is designed to increase the practitioner's knowledge of cardiovascular medicine, thereby enhancing the quality of interpretations through improved accuracy and clinical relevance.The text is divided into four sections covering all major topics in cardiology and nuclear cardiology: Basic Sciences and Cardiovascular Diseases Conventional Diagnostic Modalities Nuclear Cardiology Management of Cardiovascular Diseases

Recent years have seen numerous advances in cardiovascular nuclear medicine technology, leading to more precise diagnoses and treatment and an expanded understanding of the molecular basis for cardiac disease. Nuclear Cardiology and Multimodal Cardiovascular Imaging is a one-stop, comprehensive guide to the diagnostic and clinical implications of this complex and increasingly important technology. Part of the Braunwald family of renowned cardiology references, it provides cutting-edge coverage of multimodal cardiac imaging along with case vignettes and integrated teaching content—ideal for cardiologists, cardiology fellows, radiologists, and nuclear medicine physicians. Features all the latest cardiovascular nuclear medicine studies with practical, evidence-based implications for personalized patient evaluation and treatment. Presents a consistent, patient-centered approach using integrated case vignettes correlated with specific nuclear medicine imaging findings. Discusses patient assessment criteria, risk factor criteria, pathology, evaluation criteria, outcomes, and other clinical implications. Covers a full range of imaging technologies, including SPECT/CT, PET/CT, and CT/MR hybrid radionuclide cardiovascular imaging studies. Addresses emerging clinical applications of nuclear imaging techniques for precision-based medicine, including targeted molecular imaging and cell therapies. Includes sections on instrumentation/principles of imaging; protocols and interpretation; applications in coronary artery disease, special populations, and heart failure; artificial intelligence, and more. Contains guidelines and appropriate use documents to provide appropriate context for clinicians. Features hundreds of high-quality figures including multimodal cardiac imaging studies, anatomic illustrations, and graphs. Provides Key Point summaries, 50 procedural videos, and 100 multiple-choice questions and answers to reinforce understanding and facilitate review.

In Atlas of Nuclear Cardiology, Doctors Dilsizian and Narula have worked together with over a dozen leading authorities to capture the most up-to-date and pertinent information in the field of nuclear cardiology. This atlas is a modern and complete visual library of up-to-date information on the most current cardiovascular nuclear procedures in the clinical practice of cardiology. Together with detailed legends and extensive reference listings, the over 600 illustrations deliver comprehensive information. Diagnostic algorithms and schematic diagrams integrated with nuclear cardiology procedures are generously interspersed with color images to emphasize key concepts in cardiovascular physiology and metabolism. This vital reference provides a detailed and accurate insight into the noninvasive evaluation and quantification of myocardial perfusion, function, and metabolism.

Cardiac SPECT Imaging, Second Edition offers the best of all possible worlds--a critical topic, internationally recognized authors and cutting-edge coverage. It guides you through all aspects of the modality--from basic principles (acquiring and processing images, quality control)...and clinical applications (evaluating myocardial infarction and coronary artery disease)...to the very latest equipment. It even compares SPECT with other modalities (PET, CT, MRI, and echocardiography) to ensure smart, cost-effective decisions by both the cardiologist and nuclear medicine physician.Look for new chapters on attenuation correction, gated perfusion SPECT, radiopharmaceuticals, and myocardial perfusion SPECT, as well as the very latest on myocardial perfusion SPECT in conjunction with exercise and pharmacologic stress, assessment of perfusion/viability with Tc-99m agents, how SPECT compares with other advanced cardiac imaging modalities, and more!

​This work is devoted to understanding the recent advances in nuclear medicine and molecular imaging technologies along with their application to integrated medical therapy and future drug development. This anthology is based on the international symposium in 2015 entitled “Perspective on Nuclear Medicine for Molecular Diagnosis and Integrated Therapy. “The symposium provided an opportunity to exchange ideas on how to promote nuclear medicine technology and how to extend the technology to medical therapy and drug development, and was also a good opportunity to discuss the future perspective of nuclear medicine and molecular imaging by worldwide leaders in the field. Molecular imaging technologies have been rapidly developed worldwide in recent years. Among those developments, nuclear medicine has come to play an important role in quantitative analysis of biological process in vivo as well as in wide clinical use. With the current progress of nuclear medicine and molecular imaging, this modality has been applied for treatment monitoring and predicting its outcome with the use of optimal imaging biomarkers and suitable quantitative analysis. Truly, a new era has arrived with clinical use of nuclear medicine and molecular imaging for personalized medicine. This volume will benefit a wide variety of researchers in life science including those working in drug development, molecular imaging, and medical therapy as well as physicians who utilize diagnostic imaging.

Nuclear cardiac imaging is the diagnostic technique of using radiology and chemical markers to track cardiac performance. These imaging studies provide a wide range of information about the heart, including how much the heart contracts, the amount of blood supply to the heart and whether parts of the heart muscle are alive or dead. This is essential information for cardiologists, and nuclear imaging has become an increasingly important part of the cardiologist's armoury of diagnostic techniques. Iskandrian's text has become a leading book in the field and the fourth edition will continue the tradition. The text is updated throughout to reflect the many advances in the field, and, as a new feature, each chapter concludes with a question and answer session on important and difficult clinical issues.

Nearly 20 million nuclear medicine procedures are carried out each year in the United States alone to diagnose and treat cancers, cardiovascular disease, and certain neurological disorders. Many of the advancements in nuclear medicine have been the result of research investments made during the past 50 years where these procedures are now a routine part of clinical care. Although nuclear medicine plays an important role in biomedical research and disease management, its promise is only beginning to be realized. Advancing Nuclear Medicine Through Innovation highlights the exciting emerging opportunities in nuclear medicine, which include assessing the efficacy of new drugs in development, individualizing treatment to the patient, and understanding the biology of human diseases. Health care and pharmaceutical professionals will be most interested in this book's examination of the challenges the field faces and its recommendations for ways to reduce these impediments.

Evidence suggests that medical innovation is becoming increasingly dependent on interdisciplinary research and on the crossing of institutional boundaries. This volume focuses on the conditions governing the supply of new medical technologies and suggest that the boundaries between disciplines, institutions, and the private and public sectors have been redrawn and reshaped. Individual essays explore the nature, organization, and management of interdisciplinary R&D in medicine; the introduction into clinical practice of the laser, endoscopic innovations, cochlear implantation, cardiovascular imaging technologies, and synthetic insulin; the division of innovating labor in biotechnology; the government- industry-university interface; perspectives on industrial R&D management; and the growing intertwining of the public and proprietary in medical technology.

The decay product of the medical isotope molybdenum-99 (Mo-99), technetium-99m (Tc-99m), and associated medical isotopes iodine-131 (I-131) and xenon-133 (Xe-133) are used worldwide for medical diagnostic imaging or therapy. The United States consumes about half of the world's supply of Mo-99, but there has been no domestic (i.e., U.S.-based) production of this isotope since the late 1980s. The United States imports Mo-99 for domestic use from Australia, Canada, Europe, and South Africa. Mo-99 and Tc-99m cannot be stockpiled for use because of their short half-lives. Consequently, they must be routinely produced and delivered to medical imaging centers. Almost all Mo-99 for medical use is produced by irradiating highly enriched uranium (HEU) targets in research reactors, several of which are over 50 years old and are approaching the end of their operating lives. Unanticipated and extended shutdowns of some of these old reactors have resulted in severe Mo-99 supply shortages in the United States and other countries. Some of these shortages have disrupted the delivery of medical care. Molybdenum-99 for Medical Imaging examines the production and utilization of Mo-99 and associated medical isotopes, and provides recommendations for medical use.